Furthermore, Otto and co-workers revealed that pulmonary hypertension and decreased right ventricular systolic function developed in PAC1 receptor-deficient mice [20], supporting this cardioprotective theory. The gene discussed is ADCYAP1R1; the disease is pulmonary hypertension.